SpringWorks Therapeutics Stock Discussion

$SpringWorks Therapeutics (SWTX.US)$
Acquisition brings two FDA-approved rare tumor therapies to Merck KGaA's portfolio, creating leadership position in high-unmet-need markets.
This acquisition strategically enhances Merck KGaA's position in specialized rare tumor markets by adding two recently FDA-approved therapies with distinctive market positions. SpringWorks contributes OGSIVEO® (nirogacestat), a first-in-class therapy established as the systemic standard-of...

$SpringWorks Therapeutics (SWTX.US)$
Merck KGaA's $3.9B acquisition of SpringWorks offers 26% premium to shareholders while strategically expanding Merck's rare tumor portfolio.
The $47 per share all-cash acquisition of SpringWorks by Merck KGaA represents a 26% premium to SpringWorks' unaffected 20-day volume-weighted average price before market speculation. This translates to an equity value of approximately $3.9 billion and enterprise value of $3.4 billion (€3.0 billion), pr...

$SpringWorks Therapeutics (SWTX.US)$
Merck KGaA's $3.9B SpringWorks Acquisition Brings Revolutionary Rare Disease Treatments Under Its Wing

$SpringWorks Therapeutics (SWTX.US)$
EU Regulators Set to Rule on SpringWorks' Breakthrough Desmoid Tumor Treatment in Q2 2025

$SpringWorks Therapeutics (SWTX.US)$
Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion - reuters.com/bus...
Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds - reuters.com/bus...
It might cost cheaper to produce medicine 💊 oversea

$SpringWorks Therapeutics (SWTX.US)$ Trump won't permit this deal to go through the last thing is he wants is a foreign company that owns a US company that's not going to happen so that's my opinion but if you look at everything Trump's doing he wants drugs made in the US he doesn't want to have anybody control the ability to provide anything to the United States so if you own this stock right now and you jumping up and down for joy I don't think the deal would ever be completed with President Tr...

$SpringWorks Therapeutics (SWTX.US)$ Merck KGaA Nears Roughly $3.5 Billion Takeover of SpringWorks Therapeutics, Sources Say -- WSJ
WSJ· 5 mins ago

$SpringWorks Therapeutics (SWTX.US)$ Merck KGaA Nears Roughly $3.5 Billion Takeover of SpringWorks Therapeutics, Sources Say -- WSJ
WSJ· 5 mins ago

$SpringWorks Therapeutics (SWTX.US)$ buyout by June

$SpringWorks Therapeutics (SWTX.US)$ $85-95 next week